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A rapid  immuno-migration  test  for the  serological  detection  of canine  monocytic  ehrlichio-
sis, Witness® Ehrlichia  (WE)  (Zoetis,  France),  was  evaluated  in  528  serum  samples  from
dogs  living  in endemic  areas  of  West  and  East Africa:  Senegal  (N = 208),  Ivory  Coast  (N  =  7),
Sudan (N  = 27),  and  Djibouti  (N  =  286).  Of these  dogs,  200  were  French  military  working
dogs  (MWD)  temporarily  residing  in Africa.  The  WE  test  results  were  compared  with  those
obtained  by indirect  immunoﬂuorescence  (IFA).  The sensitivity  of  WE  was  97%  [94.2,  98.7]
with  a speciﬁcity  of 100%  [98.6,  100].  In MWD,  the  seroprevalence  (IFA)  was  7%; in nativehrlichia canis
ndirect immunoﬂuorescence test
apid immunomigration
mmunochromatography
iagnostic
dogs,  it  reached  77.1%.  This  signiﬁcant  difference  can  be  explained  by prophylactic  meas-
ures from  which  MWD  beneﬁt.  The  WE  test  represents  a simple,  fast  and reliable  test for  the
detection  of anti-Ehrlichia  canis  antibodies.  Its implementation  for the diagnosis  of clinical
cases  has  been  validated  in  the  ﬁeld, and  its use  allows  easy  detection  of  asymptomatic
dogs  that  may  be  carriers  of  E.  canis.
The Au© 2013 
. Introduction
Canine monocytic ehrlichiosis (CME) is a disease caused
y bacteria from the Anaplasmatacae family (Ehrlichia
anis), which are transmitted by ticks. In 1935, Dona-
ien and Lestoquard isolated the causative agent of a
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hemorrhagic fever from dog monocytes in Algiers, and they
classiﬁed it in the Rickettsia genus (Rickettsia canis) [1].
In 1937, the mode of transmission (vector-borne disease)
was recognized. In 1947, the bacteria were reclassiﬁed
into the Ehrlichia genus in homage to Paul Ehrlich. Dur-
ing the following decades, the same agents were identiﬁed
throughout the globe (in all the countries where the vector
is present): on the African continent, in the Middle-East,
in India and in the USA. A notable outbreak occurred in
1970 in Vietnam, when US Army dogs were devastated by
canine tropical pancytopenia [2]. Ehrlichia genus bacteria
Open access under CC BY-NC-ND license.are strictly intracellular Gram negative bacilli.
Three clinical forms appear successively in infected
dogs [3]. An acute form appears after incubation, which
ranges from 8 to 20 days (mean: 14 days). The
-NC-ND license.
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symptoms, fever and lethargy, are not speciﬁc. Hem-
orrhagic signs are often observed, including epistaxis,
petechia, hematomas and hematuria. Conﬁrming diag-
nosis requires the exploration of additional biological
parameters. First, thrombopenia is generally present
(30 × 106/mL), and the thrombocytes often suffer from
functional deﬁciency. The leukocyte count may  also vary;
initially the dogs present with leukopenia, and then, after
few days, leukocytosis appears in response to the infection.
A sub-clinical stage follows the acute form. Clinical symp-
toms disappear, and the general appearance of the dogs
improves, but they do not recover from the disease. Indeed,
the bacteria are able to persist in macrophages throughout
an animal’s life, maintaining chronic ehrlichiosis, although
this depends on the immune response of the dog. A low
proportion of dogs can eliminate the bacteria. The oth-
ers remain infected, and thrombopenia, hyperglobulinemia
and hypoalbuminemia are the main biological signs. A new
clinical manifestation of relapse may  appear when the
immune system is suppressed, especially due to another
infection. Severe weight loss, which may  lead to cachexia,
is often the trigger. Relapses may  manifest with multiple
organ dysfunction syndrome (often the liver and kidneys)
and hemorrhagic symptoms. Chronic infections are respon-
sible for autoimmune diseases such as glomerulonephritis,
articular pain, uveitis, and hemorrhagic retinitis. Anemia is
severe and non-regenerative. Thrombopenia is presented.
Dogs can die from general hemorrhaging or from a sec-
ondary infection.
Diagnosis can be established due to several elements.
Because the clinical presentations are not speciﬁc, veter-
inarians must perform a differential diagnosis, including
ruling out babesiosis, pesticidal intoxication, auto-immune
anemia and leishmaniosis. This list should be adapted
based on local epidemiological situations. Epidemiologi-
cal diagnosis is useful for the detection of acute forms
because the agent is transmitted by tick bites and the
incubation period is short. The probability of ehrlichiosis
varies by area, season and infestation of the patient by
ticks. Biological diagnosis relies on thrombopenia, hyper-
globulinemia (a limited 2-globulin peak and a larger
-globulin peak, a hyper-gammaglobulinemia that appears
10 days after inoculation) and hypoalbuminemia (these
two parameters may  vary over several years). Elevated
levels of alanine aminotransaminase (ALT: 300 UI/L) and
alkaline phosphatase (ALP: 2000 UI/L) are transient but
characteristic of the acute phase.
Laboratory tests are necessary to conﬁrm suspected
ehrlichiosis. Direct tests for bacteria can be performed on
a blood sample or from a stained organ biopsy. Morulae
may  be observed in the cytoplasm of monocytes as basophil
inclusions on a May–Grünwald–Giemsa stained smear.
Unfortunately, this diagnosis is unreliable and not very
sensitive [4], although leuko-concentration techniques can
enhance the outcome by 10%. Laboratory investigations
using culture or polymerase chain reaction (PCR) are more
reliable diagnostic methods, but they are not widely used.
Therefore, indirect tests using serological methods are the
reference diagnosis technique, primarily indirect immuno-
ﬂuorescence (IFA). Dogs are considered sero-negative if
the titer is less than 1/40, lightly positive between 1/40logy and Infectious Diseases 37 (2014) 31– 37
and 1/80, moderately positive between 1/160 and 1/320
and strongly positive if the titer is equal to or more
than 1/640 [5]. The sensitivity and the speciﬁcity of this
assay are very high, although cross-reactions exist with
Ehrlichia chaffensis, Ehrlichia ewingii, Ehrlichia ruminantium
and Anaplasma phagocytophilum. Some rapid tests have
been developed and are available for clinicians: SNAP 4Dx®
(Idexx, USA), Witness® Ehrlichia (Synbiotics, France/Zoetis,
USA), ImmunoComb® Canine Ehrlichia (Biogal, Galed Labs,
Israel), and Speed® Ehrli (BVT – Virbac, France).
The aim of our study was  to diagnosis CME  using the
Witness® Ehrlichia quick test in the ﬁeld in Africa. We  com-
pared its results with those of the IFA test performed in a
laboratory from the same sera. Our data allow analysis of
the prevalence of CME  in parts of Africa and the evaluation
of the rapid test.
2. Materials and methods
2.1. Dogs and sera
From 2000 through 2012, blood samples were col-
lected from 528 dogs: 328 native dogs and 200 French
military working dogs (MWD). The native dogs were col-
lected in Senegal (Dakar; n = 181), Djibouti (n = 120) and
Soudan (Barbar el Fugara (N13◦39′; E36◦8′), n = 27). The
dogs were investigated with the assistance of their owners.
All dogs appeared to be in good health, except 9 dogs
that were sick (2 in Senegal and 7 in Djibouti). Ticks were
frequently present on these dogs. Two hundred MWD,
mainly male Belgian Shepherds from 2–9 years old, were
included in this study. These MWD  had experienced short
stays (four months) in Africa: in Senegal (Dakar; n = 27),
Ivory Coast (Abidjan; n = 7) and Djibouti (n = 166). All of
the dogs appeared to be in good health. These dogs were
orally administered 100 mg  (approximately 3 mg/kg body-
weight) of doxycycline daily for chemoprevention of CME
[6]. An adapted acaricide product was  used regularly, and
the handlers did not report any important tick infestations.
A blood sample collected from the radial vein was
centrifuged within 24 h of collection, and the serum was
subsequently frozen at −20 ◦C.
2.2. Indirect ﬂuorescence antibodies test (IFA)
Indirect immunoﬂuorescence was performed as the ref-
erence method [7]. The E. canis antigen, supplied by the
Synbiotics Laboratory (Lyon, France), was  puriﬁed from
bacteria grown on MDH  cells. A minimum of 25% of the
cells were infected. The cells were placed on immunoﬂuo-
rescent slides and ﬁxed in cold acetone for 20 min. Standard
techniques were used with a 20-fold pre-dilution of the
serum. The examination was  performed using an ultravi-
olet microscope (Olympus microscope – 100 W Hg lamp)
at 500×. The presence of anti-Ehrlichia antibodies was
detected by a clear ﬂuorescence of intracytoplasmic moru-
lae. A negative serum is either not ﬂuorescent or the entire
cytoplasm is only slightly ﬂuorescent. Titers greater than
or equal to 1:40 were considered to be positive.
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Table 1
Comparison of the two detection methods applied to 319 native dogs from Africa.
Location Number of dogs IFA+ RIM+ IFA− RIM− IFA+ RIM− IFA− RIM+ Seroprevalence (IFA) (%)
Dakar (Senegal) 179 160 16 2 0 90.5
Barbar el Fugara (Soudan) 27 26 1 0 0 96.3
57 
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Total  319 239 
.3. Rapid immuno-migration (RIM)
Rapid immuno-migration (RIM), also known as
mmunochromatography, is one of the fastest and
ost practical techniques for detecting antibody–antigen
nteractions. In the most common iteration of this method,
n antibody speciﬁc to a given antigen is ﬁxed to col-
oidal gold molecules, which are dried as a stripe on a
hromatography paper (nitrocellulose) strip encased in a
lastic holder. The Witness® Ehrlichia test is based on RIM
echnology, and it uses an antigen from E. canis to quickly
dentify antibodies in Ehrlichia-infected dogs. Sensitized
olloidal gold particles bound to anti-E. canis antibodies
resent within the sample (whole blood, serum or plasma)
re allowed to migrate along a strip. The complex is then
aptured on a sensitized reaction line where its accumu-
ation causes the formation of a clearly visible pink band.
 control band, located at the end of the reading window,
nsures that the test was performed correctly.
.4. Statistical analyses
For the statistical analyses, 95% conﬁdence intervals
f the proportions were calculated using the exact bino-
ial method. The proportions were compared using a
hi-squared test.. Results
Table 1 shows the results obtained from both assays (IFA
nd RIM) in the sera of native African dogs in apparent good
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Fig. 1. Distribution of serological titers (IFA) of French3 0 49.5
5 0 76.5
health. The seroprevalence of CME  is particularly elevated
(96.3%) in the village of Sudan, where all of the dogs were
observed carrying ticks.
Table 2 reports the results of tests performed dur-
ing veterinary consultations on local dogs suspected of
ehrlichiosis in Dakar and Djibouti. In the nine clinical
cases presented, the correlations among clinical, hema-
tological, and biochemical signs and the results of both
tests were excellent (100%). The nine dogs suspected of
being infected tested positive with both the RIM and IFA
tests.
Table 3 shows the results obtained from both assays on
the sera of French MWD  during short stays (four months)
in Africa. The seroprevalence in these animals is low: 0% in
Abidjan, 6% in Djibouti and 14.8% in Dakar.
An overall comparison of the two  tests on 528 sera
is presented in Table 4. This table highlights the perfor-
mance of the RIM test compared to IFA, the current “gold
standard.” The RIM test has a sensitivity of 97% [94.2–98.7]
and a speciﬁcity of 100% [98.6–100]. For native dogs, the
positive predictive value is 100% [98.5–100], and the neg-
ative predictive value is 93.8% [86–97.9]. For MWD,  the
positive predictive value is 100% [71.5–100], and the neg-
ative predictive value is 98.4% [95.4–99.7]. The diagnostic
efﬁciency (overall accuracy) of RIM is 98.48%.
The distribution of serological titers observed (IFA)
ranged from 1/40 (N = 14) to 1/10,240 (N = 88) (Fig. 1). We
found a highly signiﬁcant difference (p < 106) between the
seroprevalence (IFA) of 7% for French military working dogs
and 77.1% in native African dogs.
  1/640    1/1280   1/2560 1/5160  1/10240
 MWD  (gray) and African native dogs (black).
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4. Discussion
The seroprevalence of canine monocytic ehrlichiosis is
very high throughout Africa, where it may  be considered
enzootic (Table 5). A previous study found impressive rates
of infection progression in breeding kennels. We  found
that over 77% of dogs in eight farms (64 dogs) in Abi-
djan (Ivory Coast) became seropositive during their ﬁrst
year [16]. Native African dogs are often asymptomatic,
while imported dogs without acquired immunity often
develop severe clinical forms of the disease. CME  is ubiq-
uitous below the 45th parallel, an area that corresponds
to the range of the Rhipicephalus sanguineus tick group,
which includes approximately 18 species [17]. This group
of species is especially endophilic; it is often found in ken-
nels and the crevices of walls. The prevalence of E. canis
in R. sanguineus ticks in African countries was reported
in Cameroon, where infection rates was 6 to 21%, and
in the Ivory Coast, where the rate was  27% [18,19]. In
Northeast Gabon, 253 dogs were tested in a previous
study [12], and the seroprevalence was low (3.1%), most
likely because these dogs were parasitized by Haema-
physalis leachi,  which is not considered to be a vector for
E. canis.
Additional monocytic Ehrlichia, Ehrlichia chaffeensis and
E. ewingii were recently identiﬁed by PCR in brown dog
ticks [20,21] and febrile humans in Cameroon. Although
these species were found only in Cameroon [14], it is not
possible to exclude infections by E. chaffeensis in some of
the dogs because the serological assay may  cross-react with
other members of the Ehrlichia family [5].
Furthermore, E. ruminantium are endemic in Africa. The
prevalence of E. ruminantium in dogs is unknown, but
it should be low because this bacterium is transmitted
by Amblyomma and Rhipicephalus (ex-Boophilus) ticks that
feed on domestic and wild ruminants. Only PCR is speciﬁc
enough to diagnose Ehrlichiae infections, but this technique
is rarely available in sub-Saharan Africa where Ehrlichiae
are emerging pathogens. Environmental factors such as
temperature, migration, control failure, and host popula-
tions have been known to exacerbate the spread of Ehrlichia
species [22].
In our study, the highly signiﬁcant difference between
the seroprevalence of native dogs (77%) and MWD  (7%)
is due to the prophylactic measures that beneﬁt MWD
(doxycycline and acaricides) and the short time during
which they are exposed to risk. In a previous study, the
CME  mortality and morbidity rate for the 614 dogs on
the chemoprevention protocol (100 mg  of doxycycline per
os daily) was  zero [6], and the seroconversion rate was
4% (24/614). Seropositive dogs (low titers) were asymp-
tomatic, and they generally became seronegative after
treatment. This study also shows the preventative efﬁcacy
of a monthly acaricide treatment for MWD  to avoid CME  in
endemic areas. Epidemiological data concerning animals
that live in the same endemic areas demonstrate the seri-
ous consequences (in terms of mortality and morbidity)
that are related to the absence of efﬁcient methods of tick-
control [10]. The use of an adapted acaricide product is
recommended to protect dogs that are in transit through
endemic areas against tick-transmitted diseases.
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Table 3
Comparison of the two detection methods applied to 200 military dogs after a short stay in Africa.
Location Number of dogs IFA+ RIM+ IFA− RIM− IFA+ RIM− IFA− RIM + Seroprevalence (IFA) (%)
Dakar (Senegal) 27 4 23 0 0 14.8
Abidjan (Ivory Coast) 7 0 7 0 0 0
Djibouti 166 7 156 3 0 6
Total  200 11 186 3 0 7
Table 4
Global comparison of IFA and RIM on the same 528 dog sera.
Indirect immunoﬂuorescence antibodies test (IFA)
Positive ≥ 1/40 Negative Total
Witness® Ehrlichia test
(RIM)
Positive 259 0 259
Negative 8* 261 269
261 
a
ﬁ
s
c
W
p
i
v
o
C
i
w
d
a
w
A
i
W
W
I
I
T
STotal  267 
* 1/40: 4; 1/80: 1; 1/320: 1; 1/640: 1; 1/2560: 1.
The use of the rapid Witness® Ehrlichia (WE) test
llowed us to evaluate the seroprevalence of CME  in the
eld of African countries. To date, other large serological
urveys have been conducted using an ELISA test that is
ommercially available from the IDEXX laboratory [23].
ith the SNAP 3Dx® in the Yucatan (Mexico), the sero-
revalence was  found to be 44.1% in 120 dogs [24]. In Brazil,
t was 19.8% in 2553 dogs [25]. In the United States, a sur-
ey of 982,336 dogs with this test showed a seroprevalence
f 0.6% [26]. With the SNAP 4Dx®, the seroprevalence in
anada was found to be 0.05% in 86,251 dogs [27]; in Korea,
t was found to be 6.1% in 692 dogs [28]; and in China, it
as found to be 2.17% in 600 dogs [29]. Finally, among 1100
ogs examined in Spain, the seropositivity rate was 5% [30],
nd among 919 dogs in France, it was 0.33% [31]. Thus, our
ork shows that the observed seroprevalence of CME  in
frica is the highest in the world.
The performance evaluation of the WE  test shows that
ts sensitivity (97%) and speciﬁcity (100%) are excellent.
hile IFA is a long and expensive technique to perform, the
E  test is simple, practical, fast (10 min) and unambiguous.
n addition a RIM test costs about 17 USD, twice less than an
FA test performed in a laboratory. It also has the advantage
able 5
eroprevalence surveys of CME  in Africa.
Country Seroprevalence 
Northern Africa
Morocco 44% (92/208) 
Algeria 68% (38/56)
Tunisia 54% (155/286) 
Egypt 33% (123/374) 
Eastern Africa
Sudan 98% (88/90) 
Djibouti 47% (59/126) 
Zimbabwe 34% (78/228) 
Western Africa
Ivory Coast 74% (71/96) 
Senegal 76% (51/67) 
Middle Africa
Chad 28% (5/18) 
Cameroon 32% (33/104) 
Gabon 28% (105/377) 
Southern Africa 42% (68/161) 528
of being stored at room temperature (between +2 ◦C and
+25 ◦C). These characteristics are similar to those for the
similar test (RIM – Witness®) developed for the diagnosis
of feline infections of FeLV and FIV [32].
Our results are comparable with those obtained by
ELISA (enzyme linked immunosorbent assay), both the
semiquantitative ELISA test and the purely qualitative dot-
blot ELISA test. Two  different commercially dot-ELISA kits,
ImmunoComb® Canine Ehrlichia (Biogal, Galed Labs, Israel)
and SNAP 4Dx® (Idexx, USA), were compared with the IFA
test’s detection of anti-E. canis IgG antibodies [33]. The
authors of that study concluded that the dot-ELISA kits
were speciﬁc and sensitive, especially for IFA titers at or
above 1/320. The SNAP 4Dx® test has the advantage of
identifying IgM and IgG antibodies to E. canis, A. phagocy-
tophilum, and Borrelia burgdorferi, as well as the Diroﬁlaria
immitis antigen. One study of tick-borne infections’ sero-
prevalence in MWD  in the Republic of Korea using this test
showed a large discrepancy between the results of the IFA
and ELISA testing [34]. For E. canis, they obtained 22.5% pos-
itive results with IFA and only 0.6% with the ELISA test. In
addition, a study on serum samples from 846 dog reported
that the sensitivity and speciﬁcity of the in-clinic ELISA
Year Reference
1997 Khaini personal communication
2003 Personal data
2009 [8]
1995 [9]
2000 Personal data
1999 [10]
2004 [11]
2005 [12]
2000 [10]
1991 [13]
2004 [14]
2004 [12]
1998 [15]
icrobio
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[36 B. Davoust et al. / Comparative Immunology, M
(SNAP 4Dx®) for antibodies against E. canis were 96.2%
and 100%, respectively [35]. Furthermore, the qualitative
nature of the rapid tests limits their use in monitoring clin-
ical cases, unlike the more quantitative IFA.
In conclusion, this study is the ﬁrst evaluation of the
Witness® Ehrlichia test in the ﬁeld. This Point-of-Care
(POC) test represents a simple, fast and reliable method
for the detection of anti-E. canis antibodies. Its applica-
tion for the diagnosis of clinical cases has been validated
in the ﬁeld, and its ease of use allows easy detection of
asymptomatic dogs that may  be carriers and reservoirs of
E. canis. In addition, this test can identify seronegative dogs
eligible for chemoprophylaxis (doxycycline) during a stay
in an endemic area and help prevent the spread of infec-
tion. Among 4681 dogs that had either traveled to or been
relocated from CME  endemic areas to Germany, 10.1% had
antibodies for E. canis. Traveling with dogs to these regions
puts the animals at a signiﬁcant risk of acquiring an infec-
tion [36]. Rapid tests for the detection of ehrlichiosis are
needed to monitor the health of dogs traveling through or
living in Africa.
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